00714nas a2200253   4500000000100000000000100001008004100002653003300043653003300076653001900109653002600128653001700154653001800171100001300189700001500202700001500217700001300232700001700245700001600262700001400278245013900292250001500431020001400446       2023                            d10a5-alpha reductase inhibitors10abenign prostatic hyperplasia10aalpha-blockers10acardiovascular safety10aCohort study10aheart failure1 aH. Ayele1 aP. Reynier1 aL. Azoulay1 aR. Platt1 aJ. Cabaussel1 aS. Benayoun1 aK. Filion00aThe Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study  a2023/07/23  a0002-9343